Unlikely to cause harm — often a labeling or packaging issue.
Cross Contamination
| Brand name | GABAPENTIN |
| Generic name | GABAPENTIN |
| Active ingredient(s) | GABAPENTIN |
| Distributed by / for | Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 |
| NDC | 62756-138-05 |
| Full product label | Gabapentin Capsules, USP 300 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-138-05; b) 1000-count bottles, NDC 62756-138-04, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India. |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | Nationwide in the USA |
| Quantity | 12,876 bottles |
| Recall initiated | 2025-03-04 |
| Report date | 2025-04-16 |
| Recall completed | — |
| Recall number | D-0311-2025 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗